Back

Federal Vaccine Policy and Interstate Variation in COVID-19 Vaccine Coverage in India

Mukherjee, K.

2021-08-24 health policy
10.1101/2021.08.16.21262113 medRxiv
Show abstract

IntroductionOn August 13, 2021, India completed 30 weeks of vaccination against COVID-19 for its eligible citizens. While the vaccination has made progress, there has been no study analyzing the federal/union vaccine policy and its effect on vaccination coverage across Indian states. In this context, this study analyses the federal vaccination policy and its effect on interstate variation in vaccine coverage and the correlation of state economy with vaccination coverage. MethodsThe study analyses vaccine policy documents, secondary data on vaccination coverage and state gross domestic product (GDP) available in public domain. ANOVA test has been used to assess the effect of vaccine policy on interstate vaccine coverage and correlation-regression analysis has been conducted to assess the type and strength of association between gross state domestic product and vaccination coverage. ResultsInterstate variation in vaccination coverage in the first 15 weeks was the least (F=3.5), when vaccine procurement and supply was entirely provided by the union/federal government and vaccination was limited to priority groups. However, with the extension of vaccine policy to other groups and reduction in federal government involvement in vaccine procurement, the interstate variation in vaccination coverage increased significantly (F=10.74) by the end of 30 weeks. The highest interstate variation was observed in the period between 23-30 weeks (F=25.31). State GDP was positively and strongly correlated with state vaccination coverage with a high coefficient of correlation (R=0.94) and high coefficient of determination (R2= 0.88). ConclusionsThe study finds that federal procurement and supply of vaccination among prioritized groups has been the best strategy till date to address the inequity in vaccination coverage across the states of India.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 5%
23.4%
2
Frontiers in Public Health
140 papers in training set
Top 0.7%
6.6%
3
Scientific Reports
3102 papers in training set
Top 15%
6.6%
4
BMC Public Health
147 papers in training set
Top 0.5%
6.6%
5
Vaccines
196 papers in training set
Top 0.3%
6.6%
6
PLOS Global Public Health
293 papers in training set
Top 2%
4.1%
50% of probability mass above
7
F1000Research
79 papers in training set
Top 0.3%
4.1%
8
Cureus
67 papers in training set
Top 0.9%
4.1%
9
COVID
13 papers in training set
Top 0.1%
3.7%
10
JMIR Public Health and Surveillance
45 papers in training set
Top 0.5%
3.7%
11
Disaster Medicine and Public Health Preparedness
16 papers in training set
Top 0.3%
3.2%
12
BMJ Open
554 papers in training set
Top 7%
2.8%
13
Vaccine
189 papers in training set
Top 1%
2.0%
14
BMC Medical Education
20 papers in training set
Top 0.5%
1.8%
15
International Journal of Infectious Diseases
126 papers in training set
Top 1%
1.8%
16
International Journal of Environmental Research and Public Health
124 papers in training set
Top 4%
1.7%
17
Biology
43 papers in training set
Top 1%
1.4%
18
Public Health
34 papers in training set
Top 1%
1.2%
19
Antibiotics
32 papers in training set
Top 1%
1.0%
20
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 3%
1.0%
21
Vaccine: X
19 papers in training set
Top 0.3%
0.8%
22
Frontiers in Medicine
113 papers in training set
Top 6%
0.8%
23
BMJ Global Health
98 papers in training set
Top 3%
0.5%